Urinary leukotriene E4 excretion: A biomarker of inflammatory bowel disease activity
Open Access
- 1 June 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 14 (6), 769-774
- https://doi.org/10.1002/ibd.20403
Abstract
Background. Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory disorders collectively referred to as inflammatory bowel diseases (IBD). CKeywords
This publication has 25 references indexed in Scilit:
- Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitisNature Clinical Practice Gastroenterology & Hepatology, 2006
- Urinary leukotriene E4 excretion is increased in type 1 diabetic patients: A quantification by liquid chromatography–tandem mass spectrometryProstaglandins & Other Lipid Mediators, 2005
- Is administration n-3 fatty acids by enema mucosal protective against trinitrobenzene-induced colitis in rats?Prostaglandins, Leukotrienes & Essential Fatty Acids, 1999
- Effect of methylprednisolone on the ulceration, matrix metalloproteinase distribution and eicosanoid production in a model of colitis in the rabbitInternational Journal of Experimental Pathology, 1997
- Mucosal factors inducing neutrophil movement in ulcerative colitis: the role of interleukin 8 and leukotriene B4.Gut, 1996
- Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis.Gut, 1996
- Levels of Peptidoleukotriene E4 Are Elevated in Active Crohnʼs DiseaseJournal of Pediatric Gastroenterology and Nutrition, 1995
- Effects of zileuton, a new 5-lipoxygenase inhibitor, in experimentally induced colitis in ratsInflammation Research, 1993
- Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.BMJ, 1989
- In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis.Gut, 1987